Paulson Capital Corp. – IOGEN CORPORATION, (Hereinafter Called the "Sub-Sublandlord"), - and - VARIATION BIOTECHNOLOGIES INC., (Hereinafter Called the "Sub-Subtenant"). (March 21st, 2016)
WHEREAS pursuant to a sub-sublease dated September 1, 2014 between the Sub-sublandlord and the Sub-subtenant (the "Sub-sublease"), the Sub-sublandlord leased to the Sub-subtenant the Premises on the terms and conditions described therein;
Paulson Capital Corp. – Waiver Agreement (March 2nd, 2016)
THIS WAIVER AGREEMENT (this "Agreement"), dated as of February 25, 2016, is entered into by and among VARIATION BIOTECHNOLOGIES (US), INC., a Delaware corporation (the "Borrower"); VBI Vaccines Inc., a Delaware corporation ("Holdco"); Variation Biotechnologies, Inc., a corporation incorporated under the Canada Business Corporations Act ("Canadian Sub" and together with Holdco, the "Guarantors"); and Perceptive Credit Opportunities Fund, LP (as assigned from PCOF 1, LLC, the "Lender"). Terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement defined below.